Literature DB >> 24902578

A rare case report of subcutaneous phaeohyphomycotic cyst caused by Exophiala oligosperma in an immunocompetent host with literature review.

Sithara Venkateshwar1, M Moses Ambroise, G Johny Asir, Nagaraja Mudhigeti, Anita Ramdas, K Authy, M R Shivaprakash, Reba Kanungo.   

Abstract

We report a rare case of phaeohyphomycotic cyst in an immunocompetent patient caused by Exophiala oligosperma. This fungus is earlier known to cause infections in the immunocompromised. Identification of black fungi at species level is more challenging by conventional methods, and hence final identification of the fungi was based on sequencing of rDNA. The patient was managed with surgical excision. To the best of our knowledge, this is the first case report of E. oligosperma human infection from India.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24902578     DOI: 10.1007/s11046-014-9762-4

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  25 in total

1.  A case of phaeohyphomycosis caused by Exophiala oligosperma successfully treated with local hyperthermia.

Authors:  Tatsuo Fukai; Masataro Hiruma; Yumi Ogawa; Shigaku Ikeda; Hiroshi Ikeda; Ayako Sano; Koichi Makimura
Journal:  Med Mycol J       Date:  2013

2.  Alternaria infectoria phaeohyphomycosis in a renal transplant patient.

Authors:  Eric Nulens; Emmanuel De Laere; Heidi Vandevelde; Luuk B Hilbrands; Antonius J M M Rijs; Willem J G Melchers; Paul E Verweij
Journal:  Med Mycol       Date:  2006-06       Impact factor: 4.076

3.  Disseminated subcutaneous phaeohyphomycosis caused by Exophiala oligosperma in a patient with Wegener's granulomatosis.

Authors:  Takanobu Kan; Shunsuke Takahagi; Akiko Kamegashira; Hiroshi Ooiwa; Takashi Yaguchi; Michihiro Hide
Journal:  Acta Derm Venereol       Date:  2013-05       Impact factor: 4.437

4.  Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis.

Authors:  Yi Sun; Wei Liu; Zhe Wan; Xiaohong Wang; Ruoyu Li
Journal:  Mycopathologia       Date:  2010-08-29       Impact factor: 2.574

5.  The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species.

Authors:  H Badali; M J Najafzadeh; M van Esbroeck; E van den Enden; B Tarazooie; J F G M Meis; G S de Hoog
Journal:  Med Mycol       Date:  2010-03       Impact factor: 4.076

6.  Early diagnosis of Exophiala CAPD peritonitis by 18S ribosomal RNA gene sequencing and its clinical significance.

Authors:  Susanna K P Lau; Patrick C Y Woo; Siu-kau Chiu; Kit-wah Leung; Raymond W H Yung; Kwok-yung Yuen
Journal:  Diagn Microbiol Infect Dis       Date:  2003-06       Impact factor: 2.803

7.  Molecular diversity, new species and antifungal susceptibilities in the Exophiala spinifera clade.

Authors:  R G Vitale; G S de Hoog
Journal:  Med Mycol       Date:  2002-12       Impact factor: 4.076

8.  Phaeoacremonium parasiticum subcutaneous infection in a kidney-transplanted patient successfully treated by surgery.

Authors:  C Farina; E Gotti; D Mouniée; P Boiron; A Goglio
Journal:  Transpl Infect Dis       Date:  2007-07-01       Impact factor: 2.228

9.  Molecular phylogenetics of exophiala species isolated from Korea.

Authors:  Moo Kyu Suh; Ho Chung Lee; Dong Min Kim; Gyoung Yim Ha; Jong Soo Choi
Journal:  Ann Dermatol       Date:  2012-07-25       Impact factor: 1.444

10.  A case of Exophiala oligosperma successfully treated with voriconazole.

Authors:  Bassam H Rimawi; Ramzy H Rimawi; Meena Mirdamadi; Lisa L Steed; Richard Marchell; Deanna A Sutton; Elizabeth H Thompson; Nathan P Wiederhold; Jonathan R Lindner; M Sean Boger
Journal:  Med Mycol Case Rep       Date:  2013-09-08
View more
  8 in total

Review 1.  Phaeohyphomycosis Due to Exophiala jeanselmei: An Emerging Pathogen in India--Case Report and Review.

Authors:  Swati Bhardwaj; Malini R Capoor; Sachin Kolte; Geeta Purohit; Leelavathi Dawson; Kusum Gupta; V Ramesh; Ashish Kumar Mandal
Journal:  Mycopathologia       Date:  2015-10-17       Impact factor: 2.574

Review 2.  Subcutaneous Phaeohyphomycosis Caused by Exophiala oligosperma in an Immunocompetent Host: Case Report and Literature Review.

Authors:  Hong Yang; Qing Cai; Zhiqin Gao; Guixia Lv; Yongnian Shen; Weida Liu; Lianjuan Yang
Journal:  Mycopathologia       Date:  2018-06-26       Impact factor: 2.574

3.  Onychomycosis Associated with Exophiala oligosperma in Taiwan.

Authors:  Yu-Min Wen; Ranjith Kumar Rajendran; Ying-Fang Lin; Roland Kirschner; Sindy Hu
Journal:  Mycopathologia       Date:  2015-09-16       Impact factor: 2.574

Review 4.  Cutaneous Exophiala oligosperma Infection in a Patient with Bullous Pemphigoid with a Review of the Literature.

Authors:  Chau Yee Ng; Sybren de Hoog; Hua-En Li; Yung-Yi Lee; Chun-Bing Chen; Pei-Lun Sun
Journal:  Mycopathologia       Date:  2016-12-26       Impact factor: 2.574

5.  Subcutaneous Fungal Cyst Masquerading as Benign Lesions - A Series of Eight Cases.

Authors:  Gayathri Priyadharshini; Renu G'Boy Varghese; Manjiri Phansalkar; Anita Ramdas; Authy K; Thangiah G
Journal:  J Clin Diagn Res       Date:  2015-10-01

6.  Subcutaneous Cyst Due to a Novel Fungus, Aquastroma magniostiolata: A Case Report.

Authors:  Archana Y Keche; Radhakrishna Ramchandani; Rakesh Gupta; Anuniti Mathias
Journal:  Cureus       Date:  2022-08-07

Review 7.  Clinical Spectrum, Molecular Characterization, Antifungal Susceptibility Testing of Exophiala spp. From India and Description of a Novel Exophiala Species, E. arunalokei sp. nov.

Authors:  Shreya Singh; Shivaprakash M Rudramurthy; Arvind A Padhye; Basavaraj M Hemashetter; Ranganathan Iyer; Vinaykumar Hallur; Anuradha Sharma; Sourav Agnihotri; Sunita Gupta; Anup Ghosh; Harsimran Kaur
Journal:  Front Cell Infect Microbiol       Date:  2021-07-02       Impact factor: 5.293

8.  Exophiala campbellii causing a subcutaneous palmar cyst in an otherwise healthy UK resident.

Authors:  Andrew M Borman; Mark Fraser; William Schilling; Gillian Jones; Robert Pearl; Christopher J Linton; Elizabeth M Johnson
Journal:  Med Mycol Case Rep       Date:  2020-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.